Results 221 to 230 of about 16,668 (262)

Idiopathic granulomatous mastitis: Bridging multidisciplinary care through dermatologic expertise and treatment strategies. [PDF]

JAAD Case Rep
Nadelmann ER, Randev S, Coyle CM, Halverstam C.   +3 more
europepmc   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak, Ahmed Javed, Ummi Aiman Rahman, Rumaisa Riaz, Zeeshan Imtiaz, Hassan A. Mirza, Farman U. Khan, Muhid Khattak, Fatima Javid, Abdul Moiz Khan, Adeline L. Roy, Bibek Shrestha   +11 more
wiley   +1 more source

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database. [PDF]

Front Pharmacol
Wu YY, Huang QL, Luo ZY, Song XY, Shi YY, Zheng JZ, Liu S.   +6 more
europepmc   +1 more source

Mask-Induced Dermatitis Progressing to Chronic Seborrheic Inflammation: A Case Report. [PDF]

Cureus
Bin Rakan M, Rakan M, Bin Rakan I.
europepmc   +1 more source

Designing diversity: ethical virtual agents for effective dermatological training

Melisa Kujević, Michael Schmitz, Mert Akbal, Corbin Sassen, Marvin Mergen   +4 more
openalex   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source

Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review. [PDF]

Dermatol Ther (Heidelb)
Esposito M, Giunta A, De Berardinis A, Magnanimi LM, Fargnoli MC, Patruno C, Potestio L, Napolitano M.   +7 more
europepmc   +1 more source

Validation of the Dermatologic Complexity Score for Dermatologic Triage. [PDF]

Diagnostics (Basel)
Jairath NK, Mijares J, Garg K, Beier K, Pahalyants V, Nemcevic A, Laughter M, Quinn J, Maddipuddi S, Jeha G, Qiblawi S, Ramachandran V.   +11 more
europepmc   +1 more source

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender, Rosalind Hughes, Brian Kirby   +2 more
wiley   +1 more source